Pensionfund Sabic Takes Position in Johnson & Johnson

Firm acquires 23,300 shares of healthcare giant's stock in Q4

Mar. 27, 2026 at 9:20am

Got story updates? Submit your updates here. ›

Pensionfund Sabic, a major institutional investor, acquired a new position in shares of Johnson & Johnson (NYSE:JNJ) during the fourth quarter of 2025, according to a recent 13F filing with the Securities & Exchange Commission. The firm purchased 23,300 shares of the company's stock, valued at approximately $4.8 million.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. Institutional investors closely monitor the company's performance and strategic moves, as changes in their holdings can signal broader market trends or shifts in investor sentiment.

The details

Pensionfund Sabic's new position in Johnson & Johnson represents approximately 1.3% of the firm's total investment portfolio, making the stock its 14th largest holding. The purchase comes as Johnson & Johnson's share price has risen steadily over the past year, reaching a 52-week high of $251.71 in early 2026.

  • Pensionfund Sabic acquired the 23,300 shares of Johnson & Johnson stock during the 4th quarter of 2025.

The players

Pensionfund Sabic

A major institutional investment firm that manages pension funds.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.

Got photos? Submit your photos here. ›

The takeaway

Pensionfund Sabic's investment in Johnson & Johnson signals continued confidence in the healthcare giant's long-term growth prospects, even as the stock has reached new highs. The purchase reflects the firm's belief that Johnson & Johnson remains an attractive and stable investment in the current market environment.